MENU Close
Close
  • Home
  • Services
  • Attorneys
  • Resources
  • News & Events
  • About Us
  • Contact Us
  • Join our Team
Search
Back
    Quick Links:
    Join Webinar
    Read News
    Our Location
    A
    Alternative Dispute ResolutionAntitrust & Trade RegulationAppellate Practice
    B
    Banking & Financial ServicesBankruptcy, Creditors’ Rights, and Financial RestructuringBeer LawBusiness Law
    C
    Cannabis LawConstruction LawCriminal Defense
    E
    Economic Development LawElder Care & Special Needs LawElectronic Discovery ("E-Discovery")Environmental LawEstate Planning and Administration & Wealth PreservationExecutive Compensation, Employment, ERISA, and Employee Benefits
    F
    Food, Beverage & HospitalityFranchise Law
    H
    Health Care & Life SciencesHealth Care ProvidersHigher EducationHospitals and Health Networks
    I
    ImmigrationInsurance CoverageIntellectual PropertyIntellectual Property Litigation, Arbitration, and Dispute ResolutionIntellectual Property Portfolio Strategy, Management & LicensingInternational BusinessInternet Law
    L
    Labor & EmploymentLiquor Law, Licensing, Manufacturing, and DistributionLitigation
    M
    Media LawMergers & AcquisitionsMunicipal Law
    N
    Non-Profit Law
    P
    Patent Preparation and ProsecutionPharmaceutical / Medical Devices / Pharma ServicesProducts and Consumer Liability DefenseProfessional LiabilityPublic Utilities
    R
    Real Estate, Finance, and Land Use
    S
    SecuritiesSolar Energy
    T
    TaxationTelecommunicationsTrademark & Copyright Protection & Enforcement
    V
    Venture Tech & Emerging Growth Companies
    W
    White Collar Investigations & DefenseWorkers’ Compensation
    • New Jersey
    • New York
    • Pennsylvania
    • Blogs
    • Articles
    • Podcasts
    • COVID-19 Resources
    • News
    • Events
    • Webinars
    • About Us
    • Delivering Value
    • Diversity & Inclusion
    • Meritas

    New Jersey

    400 Crossing Boulevard
    8th Floor
    Bridgewater, NJ 08807
    Phone:(908) 722-0700
    Fax:(908) 722-0755

    28 Valley Road
    Suite 1
    Montclair, NJ 07042

    New York

    7 Times Square
    21st Floor
    New York City, NY 10036
    Phone:(212) 808-0700
    Fax:(212) 808-0844

    Pennsylvania

    515 West Hamilton Street
    Suite 502
    Allentown, PA 18101
    Phone:(610) 391-1800
    Fax:(610) 391-1805

    • What sets us apart
    • Attorneys
    • Other Professionals
    • Professional Development
    • Non-Discrimination Policy

    Categories

    Hospitals and Health Systems - Audits and Reimbursement Hospitals and Health Systems - Consent and Treatment Hospitals and Health Systems - Corporate and Governance Hospitals and Health Systems - Corporate Compliance Hospitals and Health Systems - Fraud and Abuse Hospitals and Health Systems - Government Investigations Hospitals and Health Systems - Health Records Hospitals and Health Systems - HIPAA and HITECH Hospitals and Health Systems - Managed Care Hospitals and Health Systems - Medical Staff Issues Hospitals and Health Systems - Medical Training Programs Hospitals and Health Systems - Medicare Hospitals and Health Systems - Mergers, Affiliations and Joint Ventures Hospitals and Health Systems - Peer Review Hospitals and Health Systems - Professional Services Agreements Pharmaceutical Industry - Agreements with Physicians Pharmaceutical Industry - Regulatory Compliance Physicians and Providers - Audits and Reimbursement Physicians and Providers - Certifications Physicians and Providers - Credentialing Physicians and Providers - Disciplinary Actions Physicians and Providers - Employment Agreements Physicians and Providers - Fraud and Abuse Physicians and Providers - Government Investigations Physicians and Providers - HIPAA and Privacy Physicians and Providers - Impairment Physicians and Providers - Licensing Physicians and Providers - Litigation Physicians and Providers - Medicare Physicians and Providers - Peer Review Physicians and Providers - Practice Acquisitions Physicians and Providers - Practice Issues Physicians and Providers - Regulatory Compliance Physicians and Providers - Supervision Physicians and Providers - Training Uncategorized
    Blogs > The Legal Diagnosis > Governor Murphy Unveils New Initiatives...
    Norris McLaughlin, P.A.
    Visit Profile

    Governor Murphy Unveils New Initiatives to Fight the Opioid Epidemic and Adds a New Eligible Condition for the Medical Marijuana Program

    Governor Murphy Unveils New Initiatives to Fight the Opioid Epidemic and Adds a New Eligible Condition for the Medical Marijuana Program

    On Jan 23, Gov Phil Murphy announced an additional eligible condition to qualify patients for the Medical Marijuana Program (MMP) - opioid addiction.  The addition of opioid addiction as a qualifying condition is consistent with the governor's and Health Commissioner Dr. Shereef Elnahal's message to physicians encouraging them to use medical cannabis, when appropriate, in lieu of opioids when treating chronic pain.   The other eligible conditions are anxiety, chronic pain related to musculoskeletal disorders, chronic pain of visceral origin, migraine, and Tourette's Syndrome.

    The addition of the new eligible condition came as part of the governor's announcement of his new initiatives to address the opioid epidemic and the administration's commitment to a patient-centered, evidence-based approach to fight the epidemic.

    Gov Murphy outlined the following four strategies for combatting the epidemic:

    1. Increasing access to evidence-based prevention and treatment programs in our communities.  This includes the removal of prior authorization for Medication Assisted Treatment (MAT) for Medicaid patients and relaunching the REACH NJ campaign.  Additionally, the New Jersey Department of Human Services is investing in training more primary care clinicians to provide medication-assisted treatment for opioid addiction, creating new Medicaid reimbursement incentives for primary care providers to provide treatment for opioid addiction, and  establishing new Medicaid Centers of Excellence to support community-based clinicians in providing opioid addiction treatment at Rutgers Medical School and Cooper Medical School of Rowan University.  The New Jersey Department of Health will also be doubling down on syringe access programs and the Alternatives to Opioids (ALTO) program for hospital emergency departments.  Furthermore, the New Jersey Department of Corrections, Department of Health, and Department of Human Services will work on improving naloxone accessibility and expansion of MAT options in state prisons and county jails.
    2. Supporting individuals on their path to and maintenance of recovery.  This will include recovery housing and supportive housing for individuals and their families for homeless and families who are receiving child welfare; employment support for individuals who are in treatment; and peer support for those in treatment.  The lead agencies are the Department of Human Services, Department of Community Affairs, Department of Children and Families, and Department of Labor.
    3. Building sound data systems and strengthening system-wide infrastructure for the addiction community.  This will include continuing use of the Prescription Drug Monitoring Program database; utilizing Health Information Technology to connect people with addiction, healthcare providers and hospitals for better management of physical and behavioral health; and use of the Opioid Data Dashboard and NJ Cares dashboard.  The two leading agencies in this initiative are the Attorney General's Office and Department of Health.
    4. Delivering robust law enforcement to stem the supply of illicit drugs, while also supporting diversion programs.   An aggressive law enforcement initiative, with increased focus on the drug fentanyl, by utilizing the Operation Helping Hands law enforcement operation and holding individuals and organizations accountable by prosecuting them for criminal and civil charges.  The Attorney General's Office is the leading agency for this initiative.

    Gov Murphy and the New Jersey state agencies presented a united front to take action to fight the opioid epidemic.  The governor allocated $100 Million from his Fiscal Year 2019 budget in order to support the fight against the opioid epidemic.

    If you have any questions concerning this post, please contact Sandra Jarva Weiss, Chair of our Health Care & Life Sciences Practice Group, at sjarvaweiss@norris-law.com.

    Norris McLaughlin, P.A.
    Visit Profile

    Related Posts

    Resumption of In-Office Elective Surgery and Invasive Procedures in New Jersey Resumption of Ambulatory Surgery Centers Elective Surgery and Invasive Procedures in New Jersey Gov. Murphy Temporarily Expands Scope of Practice for Advanced Nurse Practitioners and Physician Assistants, While Also Providing Broad Civil Immunity to Health Care Professionals Aiding With the COVID-19 Pandemic

    Share

    Tags

    #Dr. Shereef Elnahal #Gov. Murphy #medical cannabis #Medical Marijuana Program #MMP #New Jersey #Opioid Addiction #Opioid Epidemic #Phil Murphy

    Similar Posts

    December 30, 2020
    Telemedicine and the COVID-19 Vaccination – What’s on the Horizon for 2021?
    Telemedicine and the COVID-19 Vaccination – What’s on the Horizon for 2021?
    May 20, 2020
    Resumption of Ambulatory Surgery Centers Elective Surgery and Invasive Procedures in New Jersey
    Resumption of Ambulatory Surgery Centers Elective Surgery and Invasive Procedures in New Jersey

    Helpful links

    • About Us
    • News
    • Services
    • Blogs
    • Attorneys
    • Articles
    • (COVID-19)
    • Events
    • Join our Team
    Connect

    Connect with Us

    • LinkedIn
    • Facebook
    • Twitter
    • Instagram
    • Youtube

    Join our growing team

    We are looking for quality attorneys to help us do more for our clients. At Norris McLaughlin, each attorney has the same opportunity to succeed whether you’re at the beginning of a career or pinnacle of the profession.

    Learn More

    Subscribe to our content

    Receive timely legal information delivered to your inbox

    This field is for validation purposes and should be left unchanged.
    © , Norris McLaughlin, P.A., All Rights Reserved. Attorney Advertising.
    VIEW OUR DISCLAIMER,  TERMS OF USE,  AND PRIVACY POLICY

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume you consent to our cookie policy. Learn more